Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783605735> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W2783605735 abstract "In order to enhance the lipophilicity and thus oral bioavailability of icariin (ICA) and icariside II (ICA II) of total flavonoids of epimedium (TFE), a total flavonoids of epimedium–phospholipid complex (TFE‐PLC) is prepared by wet media milling. The stabilizers Aerosi and SDS are used to formulate TFE‐PLC nanosuspensions (TFE‐PLC–Ns) to improve the dispersion of TFE–PLC. FTIR and DSC data confirms the formation of TFE‐PLC. The oil solubility of ICA and ICA II in the complex in octanol is improved nearly four times over that in TFE. The log P of ICA in TFE‐PLC is significantly increased with a value from 1.61 to 2.02 at pH 4.5, and ICA II, from 3.24 to 4.77. The mean diameter of the TFE‐PLC‐Ns is reduced from 6.166 to 0.424 μm, and its dissolution is improved over TFE. In the in vivo evaluation, TFE‐PLC‐Ns exhibits a considerable enhancement with larger AUC 0–t and shorter T max than TFE and TFE‐PLC. The relative bioavailability of ICA in TFE‐PLC and TFE‐PLC‐Ns are 181.75 and 249.05%, respectively, and for ICA II are 401.63 and 684.70%, respectively. Therefore, it suggests that TFE‐PLC‐Ns has possibilities in enhancing oral bioavailability of TFE, which may be due to its improved lipophilicity and wettability. Practical Applications : The oral bioavailability of ICA and ICA II in TFE are very low due to their poor lipophilicity and cell permeability. Here, TFE‐PLC‐Ns is proposed, which is prepared by wet media milling for improving lipophilic properties and oral bioavailability. In addition, some proofs of TFE‐PLC are investigated in detail, and TFE‐PLC‐Ns significantly increased the oral bioavailability of ICA and ICA II in TFE. Therefore, the authors recommend a potential drug vehicle of TFE‐PLC‐Ns for oral administration of ICA and ICA II, and a novel method of phospholipid complex preparation for industrial manufacture. In this article, the total flavonoids of epimedium–phospholipid complex (TFE‐PLC) is prepared to enhance the lipophilicity of icariin (ICA) and icariside II (ICA II) in TFE. Aerosi and SDS are used to formulate TFE‐PLC nanosuspensions (TFE‐PLC‐Ns) to improve the dispersion of TFE‐PLC. And finally, TFE‐PLC‐Ns exhibits enhanced oral bioavailability of ICA and ICA II compared with them in TFE and TFE‐PLC." @default.
- W2783605735 created "2018-01-26" @default.
- W2783605735 creator A5009374812 @default.
- W2783605735 creator A5025674242 @default.
- W2783605735 creator A5050080798 @default.
- W2783605735 creator A5067896558 @default.
- W2783605735 creator A5068816413 @default.
- W2783605735 creator A5071773009 @default.
- W2783605735 creator A5076955419 @default.
- W2783605735 creator A5084763313 @default.
- W2783605735 date "2018-02-20" @default.
- W2783605735 modified "2023-10-16" @default.
- W2783605735 title "Phospholipid Complex of ICA and ICA II Prepared by Wet Media Milling for Improving Bioavailability" @default.
- W2783605735 cites W1968738015 @default.
- W2783605735 cites W1992970800 @default.
- W2783605735 cites W2004039204 @default.
- W2783605735 cites W2009869660 @default.
- W2783605735 cites W2016212013 @default.
- W2783605735 cites W2027906788 @default.
- W2783605735 cites W2064348473 @default.
- W2783605735 cites W2064597901 @default.
- W2783605735 cites W2066229325 @default.
- W2783605735 cites W2075389864 @default.
- W2783605735 cites W2076864148 @default.
- W2783605735 cites W2112347682 @default.
- W2783605735 cites W2129535597 @default.
- W2783605735 cites W2133207916 @default.
- W2783605735 cites W2178594853 @default.
- W2783605735 cites W2182832921 @default.
- W2783605735 cites W2563286746 @default.
- W2783605735 cites W4243186398 @default.
- W2783605735 doi "https://doi.org/10.1002/ejlt.201700317" @default.
- W2783605735 hasPublicationYear "2018" @default.
- W2783605735 type Work @default.
- W2783605735 sameAs 2783605735 @default.
- W2783605735 citedByCount "6" @default.
- W2783605735 countsByYear W27836057352019 @default.
- W2783605735 countsByYear W27836057352020 @default.
- W2783605735 countsByYear W27836057352022 @default.
- W2783605735 countsByYear W27836057352023 @default.
- W2783605735 crossrefType "journal-article" @default.
- W2783605735 hasAuthorship W2783605735A5009374812 @default.
- W2783605735 hasAuthorship W2783605735A5025674242 @default.
- W2783605735 hasAuthorship W2783605735A5050080798 @default.
- W2783605735 hasAuthorship W2783605735A5067896558 @default.
- W2783605735 hasAuthorship W2783605735A5068816413 @default.
- W2783605735 hasAuthorship W2783605735A5071773009 @default.
- W2783605735 hasAuthorship W2783605735A5076955419 @default.
- W2783605735 hasAuthorship W2783605735A5084763313 @default.
- W2783605735 hasConcept C142724271 @default.
- W2783605735 hasConcept C155574463 @default.
- W2783605735 hasConcept C178790620 @default.
- W2783605735 hasConcept C181389837 @default.
- W2783605735 hasConcept C185592680 @default.
- W2783605735 hasConcept C201399114 @default.
- W2783605735 hasConcept C204787440 @default.
- W2783605735 hasConcept C2778918659 @default.
- W2783605735 hasConcept C2780685212 @default.
- W2783605735 hasConcept C41625074 @default.
- W2783605735 hasConcept C43617362 @default.
- W2783605735 hasConcept C55493867 @default.
- W2783605735 hasConcept C71240020 @default.
- W2783605735 hasConcept C71924100 @default.
- W2783605735 hasConcept C88380143 @default.
- W2783605735 hasConcept C98274493 @default.
- W2783605735 hasConceptScore W2783605735C142724271 @default.
- W2783605735 hasConceptScore W2783605735C155574463 @default.
- W2783605735 hasConceptScore W2783605735C178790620 @default.
- W2783605735 hasConceptScore W2783605735C181389837 @default.
- W2783605735 hasConceptScore W2783605735C185592680 @default.
- W2783605735 hasConceptScore W2783605735C201399114 @default.
- W2783605735 hasConceptScore W2783605735C204787440 @default.
- W2783605735 hasConceptScore W2783605735C2778918659 @default.
- W2783605735 hasConceptScore W2783605735C2780685212 @default.
- W2783605735 hasConceptScore W2783605735C41625074 @default.
- W2783605735 hasConceptScore W2783605735C43617362 @default.
- W2783605735 hasConceptScore W2783605735C55493867 @default.
- W2783605735 hasConceptScore W2783605735C71240020 @default.
- W2783605735 hasConceptScore W2783605735C71924100 @default.
- W2783605735 hasConceptScore W2783605735C88380143 @default.
- W2783605735 hasConceptScore W2783605735C98274493 @default.
- W2783605735 hasIssue "4" @default.
- W2783605735 hasLocation W27836057351 @default.
- W2783605735 hasOpenAccess W2783605735 @default.
- W2783605735 hasPrimaryLocation W27836057351 @default.
- W2783605735 hasRelatedWork W1842011178 @default.
- W2783605735 hasRelatedWork W2066133926 @default.
- W2783605735 hasRelatedWork W2086623451 @default.
- W2783605735 hasRelatedWork W2592924892 @default.
- W2783605735 hasRelatedWork W2910597072 @default.
- W2783605735 hasRelatedWork W3048212714 @default.
- W2783605735 hasRelatedWork W4366962935 @default.
- W2783605735 hasRelatedWork W875949149 @default.
- W2783605735 hasRelatedWork W2181926209 @default.
- W2783605735 hasRelatedWork W2183316748 @default.
- W2783605735 hasVolume "120" @default.
- W2783605735 isParatext "false" @default.
- W2783605735 isRetracted "false" @default.
- W2783605735 magId "2783605735" @default.
- W2783605735 workType "article" @default.